Nigeria Sovereign Investment Authority (NSIA) has announced a strategic partnership with BIO Ventures for Global Health (BVGH) to realise NSIA’s vision for reducing the impact of cancer in Nigeria.
As it stands, cancer is a serious health threat in Nigeria, with 116,000 new cancer cases reported each year and more than 70,000 deaths annually.
The collaboration between NSIA-LUTH Cancer and BVGH focuses on three core deliverables including the establishment of sustainable access to high quality and affordable cancer medicines and technologies; building clinical and radiation oncology expertise by helping to train and expand the skills of oncologists, and to forge international partnerships and catalyze clinical research.
Under the arrangement, the NSIA will benefit from BVGH’s African Access Initiative (AAI) which is suited to enabling both parties to achieve their objective of containing Cancer-related mortality in the country.
According to a statement from NSIA, “this partnership builds further on the solid foundation of programs led by BVGH that is delivering value to the Center and helping to improve treatment for Nigerians.
Beyond the devastating effect on the populace, cancer and its treatment result in the loss of economic resources and opportunities for patients, families, employers, and society overall.
NSIA’s healthcare investments focus on cancer with the aim of providing sustainable, high quality, and affordable treatment for Nigerians to reduce medical tourism.
The partnership with BVGH is helping to attain these objectives.
Managing Director and the Chief Executive Officer, Uche Orji said the partnership will improve access to quality cancer treatment and strengthen the economy by preventing unnecessary medical tourism for cancer treatment.
According to the Chief Medical Director, Lagos University Teaching Hospital, Prof. Chris Bode, were excited at the partner between NLCC and BVGH.
“It is expected that the combined effort and commitment of both institutions to deliver the target outcomes in terms of expected quality and scale of care will value to the Nigerian people.”
Also commenting on the partnership, the Chief Executive Officer (BVGH) Jennifer Dent, said the partnership with the NSIA-LUTH Cancer Centre is part of a broader goal of designing and building sustainable access to cancer treatments.
Dent said their position remains that advocacy for cancer prevention and domiciliation of quality treatment for patients in Nigeria must be done in parallel and at scale if the longer-term objective of reversing medical tourism and eliminating the scourge of cancer is to be achieved.
YOU SHOULD NOT MISS THESE HEADLINES FROM NIGERIAN TRIBUNE
We Have Not Had Water Supply In Months ― Abeokuta Residents
In spite of the huge investment in the water sector by the government and international organisations, water scarcity has grown to become a perennial nightmare for residents of Abeokuta, the Ogun State capital. This report x-rays the lives and experiences of residents in getting clean, potable and affordable water amidst the surge of COVID-19 cases in the state. Sovereign Wealth Fund partners NGO to stem 70,000 annual cancer deaths
Selfies, video calls and Chinese documentaries: The things you’ll meet onboard Lagos-Ibadan train
The Lagos-Ibadan railway was inaugurated recently for a full paid operation by the Nigerian Railway Corporation after about a year of free test-run. Our reporter joined the train to and fro Lagos from Ibadan and tells his experience in this report… Sovereign Wealth Fund partners NGO to stem 70,000 annual cancer deaths